CWM
OCUL icon

CIBC World Markets’s Ocular Therapeutix OCUL Stock Holding History

CIBC World Markets’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$149K Buy
+12,309
New +$150K ﹤0.01% 1149
2025
Q2 		$161K Sell
17,321
-17,763
-51% -$139K ﹤0.01% 1323
2025
Q1 		$257K Buy
35,084
+20,522
+141% +$158K ﹤0.01% 1327
2024
Q4 		$124K Buy
+14,562
New +$142K ﹤0.01% 1192

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CIBC World Markets's OCUL Position: Q4 2025 in Review

CIBC World Markets opened a new position in Ocular Therapeutix (OCUL) in Q4 2025: 12,309 shares worth $149K. The stake represents ﹤0.01% of the portfolio and ranks #1149 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in OCUL as recently as Q2 2025.

CIBC World Markets first reported a position in OCUL in Q4 2024 and has held it in 4 quarters since. The position peaked at $257K in Q1 2025. 249 funds tracked by Wall St. Rank hold OCUL as of Q4 2025.

  • CIBC World Markets held 12,309 shares of Ocular Therapeutix worth $149K as of Q4 2025.
  • Ocular Therapeutix was a new CIBC World Markets position in Q4 2025.
  • Ocular Therapeutix made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #1149 holding.
  • CIBC World Markets first reported a position in Ocular Therapeutix in Q4 2024 and has held it in 4 quarters since.
  • CIBC World Markets's Ocular Therapeutix position peaked at $257K in Q1 2025.
  • 249 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.